Ervebo® (Ebola Zaire Vaccine, Live) – New vaccine approval
December 19, 2019 - The FDA announced the approval of Merck’s Ervebo (Ebola Zaire Vaccine, Live), for the prevention of disease caused by Zaire ebolavirus in individuals 18 years of age and older.
Download PDF
